The Alpha-2 adrenergic receptors
Author(s)
Bibliographic Information
The Alpha-2 adrenergic receptors
(Receptors)
Humana Press, c1988
- Other Title
-
Alpha-two adrenergic receptors
Available at 3 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographies and index
Description and Table of Contents
Table of Contents
Section 1: Historical Perspective.- 1 alpha-2 Adrenergic Receptors: A Historical Perspective.- Perspective.- References.- Section 2: Characterization of the Receptor and its Binding Site.- 2 Biochemistry of alpha-2 Adrenergic Receptors.- 1. Radiolabeled Ligands for the Reversible Labeling of alpha-2 Adrenergic Receptors.- 1.1. [3H]UK 14,304.- 1.2. [3H]Yohimbine/[3H]Rauwolscine.- 1.3. 125I-Rauwolscine-pAPC.- 1.4. [3H]Idazoxan.- 2. Radiolabeled Ligands for the Irreversible Labeling of alpha-2 Adrenergic Receptors.- 2.1. [3H]Phenoxybenzamine.- 2.2. [3H]p-Azidoclonidine.- 2.3. [3H]SKF 102229.- 2.4. 125I-Rauwolscine-AzPC.- 3. Biochemical Isolation of alpha-2 Adrenergic.- Receptors.- 3.1. Solubilization of alpha-2 Adrenergic Receptors from Membranes.- 3.2. Approaches to the Purification of alpha-2 Adrenergic Receptors.- 4. Structural Aspects of the alpha-2 Adrenergic Receptors.- 5. Conclusions.- References.- Section 3: Biochemical Mechanisms of Receptor Action.- 3 Mechanisms for Inhibition of Adenylate Cyclase by alpha-2 Adrenergic Receptors.- 1. Introduction.- 2. Components and Mechanisms Involved in Stimulation of Adenylate Cyclase.- 3. Components Involved in Inhibition of Adenylate Cyclase by alpha-2 Adrenergic Agonists.- 3.1. A Guanine Nucleotide-Binding Protein Is Involved in Inhibition of Adenylate Cyclase by alpha-2 Adrenergic Agonists.- 3.2. Identification of the Inhibitory Guanine Nucleotide-Binding Protein Gi by Pertussis Toxin.- 3.3. Purification of Gi and Characterization of the Purified Protein.- 3.4. Analogous G-Proteins.- 4. Mechanisms Involved in Inhibition of Adenylate Cyclase in the Plasma Membrane.- 4.1. Inhibition of Adenylate Cyclase by ?/? Complexes Mimics Hormonal Inhibition of the Enzyme.- 4.2. Release of ?/? Complexes by Activated Gi Cannot Be the Sole Mechanism Responsible for Inhibition of Adenylate Cyclase.- 5. Modulation of GiMediated Adenylate Cyclase Inhibition.- 5.1. Modulation by GTP and Stable GTP Analogs.- 5.2. Modulation by Sodium Ions.- 5.3. Divalent Cations Regulate Adenylate Cyclase at Several Sites.- 5.4. Inhibitory Coupling of alpha-2 Adrenergic Receptors Is Highly Susceptible to Alkylation by N-Ethylmaleimide.- 5.5. alpha-2 Adrenergic Inhibition of Adenylate Cyclase Can Be Specifically Blocked by Limited Proteolysis.- 5.6. Protein Kinase C Interferes with alpha-2 Adrenergic Inhibition of Adenylate Cyclase in Human Platelet Membranes.- 6. Conclusion.- References.- Section 4: Correlation of Receptor Binding and Function.- 4 Structure-Activity Relationships for alpha-2 Adrenergic Receptor Agonists and Antagonists.- 1. Introduction.- 2. alpha-Adrenergic Receptor Subclassification.- 2.1. Methods of Subclassification.- 2.2. alpha-2 Adrenergic Receptor Heterogeneity.- 2.3. Postsynaptic vs Presynaptic alpha-2 Adrenergic Receptors.- 3. Structure-Activity Relationships of alpha-2 Adrenergic Receptors.- 3.1. Stereochemical Requirements of alpha-2 Adrenergic Receptors.- 3.2. Structure-Activity Relationships of the alpha-2 Adrenergic Receptor for the Phenethylamines.- 3.3. Structure-Activity Relationships of the alpha-2 Adrenergic Receptor for the Imidazolines.- 3.4. Structure-Activity Relationships of the alpha-2 Adrenergic Receptor for Antagonists.- 3.5. Model of the alpha-2 Adrenergic Receptor Based on the Structural Requirements for alpha-2 Adrenergic Receptor Antagonists.- 4. Summary and Conclusions.- References.- 5 Functions Mediated by alpha-2 Adrenergic Receptors.- 1. Introduction.- 2. alpha-2 Adrenergic Receptors in the Cardiovascular System.- 2.1. Cardiovascular Effects Mediated by Central alpha-2 Adrenergic Receptors.- 2.2. Peripheral Arterial alpha-2 Adrenergic Receptors.- 2.3. Peripheral Venous Circulation.- 2.4. Myocardium.- 2.5. alpha-2 Adrenergic Receptors in the Kidney.- 3. Functions Mediated by alpha-2 Adrenergic Receptors in Various Noncardiovascular Tissues.- 3.1. Inhibition of Neurotransmitter Release.- 3.2. Functional Role of Platelet alpha-2 Adrenergic Receptors.- 3.3. Sedation Mediated by alpha-2 Adrenergic Receptors.- 3.4. Interaction of alpha-2 Adrenergic Receptors and Opiate Receptors in the Central Nervous System.- 3.5. Suppression of Insulin Release by alpha-2 Adrenergic Receptors.- 3.6. alpha-2 Adrenergic Receptors in the Gastrointestinal Tract.- 3.7. alpha-2 Adrenergic Receptors in Uterus.- 4. Correlation Between alpha-2 Adrenergic Receptor Occupancy (Binding) and Function.- 4.1. Occupancy-Response Relationships.- 4.2. Second Messengers.- 5. Comparison of Drug Potencies in Biochemical and Physiologic Assay Systems for alpha-2 Adrenergic Receptors.- 6. Summary and Conclusions.- References.- Section 5: Receptor Regulation.- 6 Regulation of alpha-2 Adrenergic Receptors.- 1. Introduction.- 2. Physiologic Regulation of alpha-2 Adrenergic Receptors.- 2.1. Developmental Changes in alpha-2 Adrenergic Receptors.- 2.2. alpha-2 Adrenergic Receptors in States of Altered Nutritional Status.- 2.3. Changes in alpha-2 Adrenergic Receptors with Exercise.- 2.4. alpha-2 Adrenergic Receptors in the Menstrual (Estrus) Cycle and Pregnancy.- 3. Pharmacologic Regulation of alpha-2 Adrenergic Receptors.- 3.1. Homologous Regulation of alpha-2 Adrenergic Receptors.- 3.2. Heterologous Regulation of alpha-2 Adrenergic Receptors.- 4. Disease-Related Changes in alpha-2 Adrenergic Receptors.- 4.1. Cardiovascular Diseases.- 4.2. Platelet Disorders.- 4.3. Psychiatric Disorders.- 4.4. Miscellaneous Diseases.- 5. Summary and Conclusions.- References.- Section 6: Future Vistas.- 7 What Happens Next? A Hypothesis Linking the Biochemical and Electrophysiological Sequelae of alpha-2 Adrenergic Receptor Occupancy with the Diverse Receptor-Mediated Physiological Effects.- 1. Introduction.- 2. Biochemical Consequences of alpha-2 Adrenergic Receptor Occupancy in Addition to the Inhibition of Adenylate (Cyclase.- 2.1. alpha-2 Adrenergic Receptors and Na+/H+ Exchange.- 2.2. alpha-2 Adrenergic Receptors and Ca2+.- 3. Electrophysiological Consequences of alpha-2 Adrenergic Receptor Occupancy.- 3.1. alpha-2 Adrenergic Receptors and K+ Conductance.- 3.2. alpha-2 Adrenergic Receptors and Ca2+ Conductance.- 3.3. GTP-Binding Proteins Are Involved in alpha-2 Adrenergic Receptor-Mediated Modulation of Ion Channels.- 4. Hypothesis: Na+/H+ Exchange, Changes in Ca2+ Availability and Ion Channel Conductances Interact to Elicit alpha-2 Adrenergic Receptor-Mediated Physiological Effects.- 5. Summary and Future Perspectives.- References.
by "Nielsen BookData"